Similar articles for PMID: 28624204

Year	Number of Results
2004	1
2005	1
2015	9
2016	6
2017	19
2018	12
2019	10
2020	4
2021	1
2022	1
2024	0

1

CRISPR/Cas9-Directed Reassignment of the GATA1 Initiation Codon in K562 Cells to Recapitulate AML in Down Syndrome.

Bloh KM, Bialk PA, Gopalakrishnapillai A, Kolb EA, Kmiec EB. Bloh KM, et al. Mol Ther Nucleic Acids. 2017 Jun 16;7:288-298. doi: 10.1016/j.omtn.2017.04.009. Epub 2017 Apr 13. Mol Ther Nucleic Acids. 2017. PMID: 28624204 Free PMC article.

2

Modeling Transient Abnormal Myelopoiesis Using Induced Pluripotent Stem Cells and CRISPR/Cas9 Technology.

Barwe SP, Sidhu I, Kolb EA, Gopalakrishnapillai A. Barwe SP, et al. Mol Ther Methods Clin Dev. 2020 Sep 16;19:201-209. doi: 10.1016/j.omtm.2020.09.007. eCollection 2020 Dec 11. Mol Ther Methods Clin Dev. 2020. PMID: 33102613 Free PMC article.

3

Mechanism of KIT gene regulation by GATA1 lacking the N-terminal domain in Down syndrome-related myeloid disorders.

Kanezaki R, Toki T, Terui K, Sato T, Kobayashi A, Kudo K, Kamio T, Sasaki S, Kawaguchi K, Watanabe K, Ito E. Kanezaki R, et al. Sci Rep. 2022 Nov 29;12(1):20587. doi: 10.1038/s41598-022-25046-z. Sci Rep. 2022. PMID: 36447001 Free PMC article.

4

Analyses of point mutation repair and allelic heterogeneity generated by CRISPR/Cas9 and single-stranded DNA oligonucleotides.

Bialk P, Sansbury B, Rivera-Torres N, Bloh K, Man D, Kmiec EB. Bialk P, et al. Sci Rep. 2016 Sep 9;6:32681. doi: 10.1038/srep32681. Sci Rep. 2016. PMID: 27609304 Free PMC article.

5

Insertional Mutagenesis by CRISPR/Cas9 Ribonucleoprotein Gene Editing in Cells Targeted for Point Mutation Repair Directed by Short Single-Stranded DNA Oligonucleotides.

Rivera-Torres N, Banas K, Bialk P, Bloh KM, Kmiec EB. Rivera-Torres N, et al. PLoS One. 2017 Jan 4;12(1):e0169350. doi: 10.1371/journal.pone.0169350. eCollection 2017. PLoS One. 2017. PMID: 28052104 Free PMC article.

6

Single-Strand Annealing Plays a Major Role in Double-Strand DNA Break Repair following CRISPR-Cas9 Cleavage in Leishmania.

Zhang WW, Matlashewski G. Zhang WW, et al. mSphere. 2019 Aug 21;4(4):e00408-19. doi: 10.1128/mSphere.00408-19. mSphere. 2019. PMID: 31434745 Free PMC article.

7

A Survey of Validation Strategies for CRISPR-Cas9 Editing.

Sentmanat MF, Peters ST, Florian CP, Connelly JP, Pruett-Miller SM. Sentmanat MF, et al. Sci Rep. 2018 Jan 17;8(1):888. doi: 10.1038/s41598-018-19441-8. Sci Rep. 2018. PMID: 29343825 Free PMC article.

8

CRISPR/Cas9-mediated correction of human genetic disease.

Men K, Duan X, He Z, Yang Y, Yao S, Wei Y. Men K, et al. Sci China Life Sci. 2017 May;60(5):447-457. doi: 10.1007/s11427-017-9032-4. Epub 2017 May 3. Sci China Life Sci. 2017. PMID: 28534256 Review.

9

Efficient and modular CRISPR-Cas9 vector system for Physcomitrella patens.

Mallett DR, Chang M, Cheng X, Bezanilla M. Mallett DR, et al. Plant Direct. 2019 Sep 12;3(9):e00168. doi: 10.1002/pld3.168. eCollection 2019 Sep. Plant Direct. 2019. PMID: 31523744 Free PMC article.

10

Bacterial CRISPR/Cas DNA endonucleases: A revolutionary technology that could dramatically impact viral research and treatment.

Kennedy EM, Cullen BR. Kennedy EM, et al. Virology. 2015 May;479-480:213-20. doi: 10.1016/j.virol.2015.02.024. Epub 2015 Mar 7. Virology. 2015. PMID: 25759096 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

58 results

Results by year